Inhibitors of NF-κB signaling: 785 and counting

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Oncogene

• Publication date

  2006-10-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.onc.1209982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway

  2006influential reference
• Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks.

  2006cited by this paper
• Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance

  2006cited by this paper
• Mutations in the NF-κB signaling pathway: implications for human disease

  2006cited by this paper
• Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression

  2006cited by this paper
• Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models

  2006cited by this paper
• Targeted CML therapy: controlling drug resistance, seeking cure.

  2006cited by this paper
• Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischemic acute renal failure.

  2006cited by this paper
• Current insights into the regulation of programmed cell death by NF-κB

  2006cited by this paper
• Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate.

  2006cited by this paper
• Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses

  2006influential reference
• Introduction to NF-κB: players, pathways, perspectives

  2006influential reference
• Cross-talk between nuclear receptors and nuclear factor κB

  2006cited by this paper
• Preadministration of High-Dose Salicylates, Suppressors of NF-κB Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy

  2006cited by this paper
• The MC160 Protein Expressed by the Dermatotropic Poxvirus Molluscum Contagiosum Virus Prevents Tumor Necrosis Factor Alpha-Induced NF-κB Activation via Inhibition of I Kappa Kinase Complex Formation

  2006cited by this paper
• Hepatitis C Virus Nonstructural 5B Protein Regulates Tumor Necrosis Factor Alpha Signaling through Effects on Cellular IκB Kinase

  2006cited by this paper
• IκB kinase complexes: gateways to NF-κB activation and transcription

  2006influential reference
• Raloxifene-Induced Myeloma Cell Apoptosis: A Study of Nuclear Factor-κB Inhibition and Gene Expression Signature

  2006cited by this paper
• Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity.

  2006cited by this paper
• Antitumoural Effects of the Pyridyl Cyanoguanidine CHS 828 on Three Different Types of Neuroendocrine Tumours Xenografted to Nude Mice

  2006cited by this paper
• Regulation of NF‐κB Signaling by Decoy Oligodeoxynucleotides

  2006cited by this paper
• Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats

  2005cited by this paper
• Targeting β-Transducin Repeat–Containing Protein E3 Ubiquitin Ligase Augments the Effects of Antitumor Drugs on Breast Cancer Cells

  2005cited by this paper
• Allergen-induced peribronchial fibrosis and mucus production mediated by IκB kinase β-dependent genes in airway epithelium

  2005cited by this paper
• Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms.

  2005cited by this paper
• Inhibition of interleukin-12 expression in diltiazem-treated dendritic cells through the reduction of nuclear factor-kappa B transcriptional activity.

  2005cited by this paper
• Inhibitor κB-like proteins from a polydnavirus inhibit NF-κB activation and suppress the insect immune response

  2005cited by this paper
• Dipyridamole Selectively Inhibits Inflammatory Gene Expression in Platelet–Monocyte Aggregates

  2005cited by this paper
• Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation

  2005cited by this paper
• The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation.

  2005cited by this paper
• Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-κB pathway

  2005cited by this paper
• Validation of IKKβ as therapeutic target in airway inflammatory disease by adenoviral‐mediated delivery of dominant‐negative IKKβ to pulmonary epithelial cells

  2005cited by this paper
• Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation.

  2005cited by this paper
• Proteolytic Cleavage of the p65-RelA Subunit of NF-κB during Poliovirus Infection*

  2005cited by this paper
• FK506 inhibits tumour necrosis factor‐α secretion in human keratinocytes via regulation of nuclear factor‐κB

  2005cited by this paper
• ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-beta1, PDGF-BB, NF-kappaB and MMP-2,9.

  2005cited by this paper
• Transcription factor cross-talk: the estrogen receptor and NF-kappaB.

  2005cited by this paper
• Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.

  2005cited by this paper
• NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors.

  2005cited by this paper
• A p105-based Inhibitor Broadly Represses NF-κB Activities*

  2004influential reference
• C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.

  2004cited by this paper
• Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression

  2004cited by this paper
• Inhibition of NF-κB Activation by Peptides Targeting NF-κB Essential Modulator (NEMO) Oligomerization*

  2004cited by this paper
• Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 Cells

  2004cited by this paper
• A Virulence Factor of Myxoma Virus Colocalizes with NF-κB in the Nucleus and Interferes with Inflammation

  2004cited by this paper
• Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation

  2004cited by this paper
• Inhibition of the endothelial cell activation by antithrombin in vitro

  2004cited by this paper
• HIV-1 Protease Inhibitor, Ritonavir

  2004cited by this paper
• The development of proteasome inhibitors as anticancer drugs.

  2004cited by this paper
• Locked nucleic acids (LNA): versatile tools for designing oligonucleotide decoys with high stability and affinity.

  2004cited by this paper
• The IKK NF-κB system: a treasure trove for drug development

  2004cited by this paper
• HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation.

  2004cited by this paper
• Role of cysteine residues of p65/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential.

  2004influential reference
• Rapamycin suppresses experimental aortic aneurysm growth.

  2004cited by this paper
• Anti-Inflammatory Effects of Moxifloxacin on Activated Human Monocytic Cells: Inhibition of NF-κB and Mitogen-Activated Protein Kinase Activation and of Synthesis of Proinflammatory Cytokines

  2004cited by this paper
• Caspase‐8 and caspase‐10 activate NF‐κB through RIP, NIK and IKKα kinases

  2003cited by this paper
• An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.

  2003cited by this paper
• Evidence that reactive oxygen species do not mediate NF‐κB activation

  2003cited by this paper
• Jesterone dimer, a synthetic derivative of the fungal metabolite jesterone, blocks activation of transcription factor nuclear factor kappaB by inhibiting the inhibitor of kappaB kinase.

  2003cited by this paper
• Transcription factors as molecular targets: molecular mechanisms of decoy ODN and their design.

  2003cited by this paper
• Inhibition of TNF-alpha-induced RANTES expression in human hepatocyte-derived cells by fibrates, the hypolipidemic drugs.

  2003cited by this paper
• Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κB*

  2003cited by this paper
• BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice*

  2003cited by this paper
• NF-κB as a Therapeutic Target in Multiple Myeloma*

  2002cited by this paper
• B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity.

  2002cited by this paper
• Retroinfusion of NFκB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs

  2002cited by this paper
• A Small Molecule Ubiquitination Inhibitor Blocks NF-κB-dependent Cytokine Expression in Cells and Rats*

  2002cited by this paper
• Cutting Edge: Salmonella AvrA Effector Inhibits the Key Proinflammatory, Anti-Apoptotic NF-κB Pathway1

  2002influential reference
• I-κB Kinases α and β Have Distinct Roles in Regulating Murine T Cell Function1

  2002cited by this paper
• The Non-ankyrin C Terminus of IκBα Physically Interacts with p53 in Vivo and Dissociates in Response to Apoptotic Stress, Hypoxia, DNA Damage, and Transforming Growth Factor-β1-mediated Growth Suppression*

  2002cited by this paper
• The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.

  2001cited by this paper
• Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones*

  2001influential reference
• Tumor necrosis factor receptor-associated factors (TRAFs)

  2001cited by this paper
• Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ

  2001cited by this paper
• Oral administration of the anti-inflammatory substance triflusal results in the downregulation of constitutive transcription factor NF-kappaB in the postnatal rat brain.

  2000cited by this paper
• Effects of Clarithromycin on Cultured Human Nasal Epithelial Cells and Fibroblasts

  2000cited by this paper
• Inhibition of NF-κB Activation by Arsenite through Reaction with a Critical Cysteine in the Activation Loop of IκB Kinase*

  2000influential reference
• Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex

  2000cited by this paper
• Inhibition of Interleukin-1-stimulated NF-κB RelA/p65 Phosphorylation by Mesalamine Is Accompanied by Decreased Transcriptional Activity*

  1999cited by this paper
• Activation of Phosphatidylinositol 3-Kinase in Response to Interleukin-1 Leads to Phosphorylation and Activation of the NF-κB p65/RelA Subunit

  1999cited by this paper
• Immunosuppressant PG490 (Triptolide) Inhibits T-cell Interleukin-2 Expression at the Level of Purine-box/Nuclear Factor of Activated T-cells and NF-κB Transcriptional Activation*

  1999cited by this paper
• Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome.

  1999cited by this paper
• Activators and target genes of Rel/NF-κB transcription factors

  1999influential reference
• Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway

  1999cited by this paper
• Overexpression of γ-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1

  1999cited by this paper
• Mediation by NF-κB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors

  1998cited by this paper
• Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-kappaB expression and lymphocyte function.

  1998cited by this paper
• Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb

  1998cited by this paper
• Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis

  1998cited by this paper
• Lactacystin, Proteasome Function, and Cell Fate*

  1998cited by this paper
• Overexpression of Manganese Superoxide Dismutase Suppresses Tumor Necrosis Factor-induced Apoptosis and Activation of Nuclear Transcription Factor-κB and Activated Protein-1*

  1998cited by this paper
• Activation of the Heat Shock Factor 1 by Serine Protease Inhibitors

  1998cited by this paper
• The yopJ locus is required for Yersinia‐mediated inhibition of NF‐κB activation and cytokine expression: YopJ contains a eukaryotic SH2‐like domain that is essential for its repressive activity

  1998cited by this paper
• IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation.

  1998cited by this paper
• JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action?

  1998cited by this paper
• Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor‐κB activation in J774 macrophages

  1998cited by this paper
• NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176

  1998cited by this paper
• An allosteric drug, o,o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.

  1998cited by this paper
• Interleukin‐11: A gp130 Cytokine

  1998cited by this paper
• Role of IKK1 and IKK2 in Lipopolysaccharide Signaling in Human Monocytic Cells*

  1998cited by this paper

• Alveolar epithelial NF-κB/RelA guards the lung against bacterial infection.

  2026cites this paper
• Design, Synthesis, and AChE Inhibition of 4-Amino-tetrahydroquinoline Derivatives: Molecular Docking and Biological Evaluation

  2025cites this paper
• In vitro anti-inflammatory activity of ethyl acetate extract and nicotinic acid from Cordyceps neovolkiana DL0004 in RAW 264.7 macrophages

  2025cites this paper
• Cardamonin Inhibits the Nuclear Translocation and DNA Binding of RelA in the Tumor Necrosis Factor-α-Induced NF-κB Signaling Pathway in Human Lung Adenocarcinoma A549 Cells

  2025cites this paper
• Canonical NF-κB Pathway as a Central Regulator of Obesity-Associated Inflammation: A Narrative Review

  2025cites this paper
• Discovery of paradoxical genes: reevaluating the prognostic impact of overexpressed genes in cancer

  2025cites this paper
• 1′-Acetoxychavicol Acetate Selectively Downregulates Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) Expression

  2025cites this paper
• An optimised Bcl‐3 inhibitor for melanoma treatment

  2025cites this paper
• Developmental toxicity of co-exposure of heavy metal and polystyrene microplastics in Xenopus laevis embryo.

  2025cites this paper
• Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapy

  2025influential citation
• Natural products targeting the NF-κB signaling pathway:Potential therapeutic drug candidates.

  2025cites this paper
• The Anticancer Activities of Natural Terpenoids That Inhibit Both Melanoma and Non-Melanoma Skin Cancers

  2024cites this paper
• Structure–Activity Relationship of Oleanane-Type Pentacyclic Triterpenoids on Nuclear Factor κB Activation and Intracellular Trafficking and N-Linked Glycosylation of Intercellular Adhesion Molecule-1

  2024cites this paper
• Sesquiterpene Lactones Containing an α-Methylene-γ-Lactone Moiety Selectively Down-Regulate the Expression of Tumor Necrosis Factor Receptor 1 by Promoting Its Ectodomain Shedding in Human Lung Adenocarcinoma A549 Cells

  2024cites this paper
• A Cross-Sectional Study to Evaluate the Role of the Nuclear Factor Kappa B (Nf-κB) Pathway in Regulating the Cytokine Cascade and as a Potential Therapeutic Target in Leprosy

  2024cites this paper
• Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review

  2024cites this paper
• Cedrol attenuates acute ischemic injury through inhibition of microglia-associated neuroinflammation via ERβ-NF-κB signaling pathways.

  2024cites this paper
• Adipose Tissues Have Been Overlooked as Players in Prostate Cancer Progression

  2024cites this paper
• A Novel Quinoline Inhibitor of the Canonical NF-κB Transcription Factor Pathway

  2024cites this paper
• SARS-CoV-2 ORF3a induces COVID-19-associated kidney injury through HMGB1-mediated cytokine production

  2024cites this paper
• Mesenchymal stem cell-derived exosomes as a new drug carrier for the treatment of spinal cord injury: A review

  2024cites this paper
• Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity

  2024cites this paper
• Alantolactone derivatives inhibit the tumor necrosis factor α-induced nuclear factor κB pathway by a different mechanism from alantolactone.

  2024cites this paper
• Anti-inflammatory and cytoprotective polypharmacology of Canephron N reveals targeting of the IKK-NF-κB and p38-MK2-RIPK1 axes.

  2024cites this paper
• Porphyrin derivatives inhibit tumor necrosis factor α-induced gene expression and reduce the expression and increase the cross-linked forms of cellular components of the nuclear factor κB signaling pathway.

  2024cites this paper
• The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms

  2024cites this paper
• The NF-κB1/p50 Subunit Influences the Notch/IL-6-Driven Expansion of Myeloid-Derived Suppressor Cells in Murine T-Cell Acute Lymphoblastic Leukemia

  2024cites this paper
• NF-κB c-REL-OTUD4 axis regulates B-cell receptor in B-cell lymphoma

  2023cites this paper
• Modulation of cell physiology by bispecific nanobodies enabling changes in the intracellular localization of organelle proteins.

  2023cites this paper
• Transcription factors in the development and treatment of immune disorders

  2023influential citation
• Oxoaporphine Pr(III) complex inhibits hepatocellular carcinoma progression and metastasis by disrupting tumor cell-macrophage crosstalk.

  2023cites this paper
• Role of the redox state of the Pirin-bound cofactor on interaction with the master regulators of inflammation and other pathways

  2023cites this paper
• Mycoplasma hyorhinis infection promotes TNF-α signaling and SMAC mimetic-mediated apoptosis in human prostate cancer

  2023cites this paper
• From reactive species to disease development: Effect of oxidants and antioxidants on the cellular biomarkers

  2023cites this paper
• Cadmium exposure disturbs myocardial lipid signature and induces inflammation in C57BL/6J mice.

  2023cites this paper
• Targeting the Cysteine Redox Proteome in Parkinson’s Disease: The Role of Glutathione Precursors and Beyond

  2023cites this paper
• The Role of Tambelo Extract (Bactronophorus thoracites) in Mice-Induced Lipopolysaccharide: Food Health Benefits

  2023cites this paper
• Cooperative NF-κB and Notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer

  2023cites this paper
• Elderberry extract improves molecular markers of endothelial dysfunction linked to atherosclerosis

  2023cites this paper
• P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer.

  2023cites this paper
• Molecular determinants of the response of cancer cells towards geldanamycin and its derivatives.

  2023cites this paper
• CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors.

  2023cites this paper
• The Role of Macrophages in Cardiac Function and Disease

  2023cites this paper
• Emphasis on Adipocyte Transformation: Anti-Inflammatory Agents to Prevent the Development of Cancer-Associated Adipocytes

  2023cites this paper
• Effect and mechanism of chlorogenic acid on cognitive dysfunction in mice by lipopolysaccharide-induced neuroinflammation

  2023cites this paper
• Anti–NF-κB peptide derived from nuclear acidic protein attenuates ovariectomy-induced osteoporosis in mice

  2023cites this paper
• Isolation and evaluation of antiviral plant compounds against respiratory disease-causing viruses: a review

  2023cites this paper
• Harnessing oxidative stress for anti-glioma therapy.

  2022cites this paper
• Leptin signaling in breast cancer and its crosstalk with peroxisome proliferator-activated receptors α and γ

  2022cites this paper
• NF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?

  2022cites this paper
• Blocking TNF signaling may save lives in COVID-19 infection

  2022cites this paper
• PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

  2022cites this paper
• Anti-Inflammatory Extract from Soil Algae Chromochloris zofingiensis Targeting TNFR/NF-κB Signaling at Different Levels

  2022cites this paper
• Sars-COV-2 infection leads to neurodegenerative or neuropsychiatric diseases

  2022cites this paper
• A systematic analysis of gene–gene interaction in multiple sclerosis

  2022cites this paper
• A Nanocurcumin and Pyrroloquinoline Quinone Formulation Prevents Hypobaric Hypoxia-Induced Skeletal Muscle Atrophy by Modulating NF-κB Signaling Pathway

  2022cites this paper
• Synthesis and Evaluation of NF-κB Inhibitory Activity of Mollugin Derivatives

  2022cites this paper
• Anticancer and apoptotic activity in neuroblastoma SK‐N‐SH using phospholipid extract from bone of Scomberomorus niphonius

  2022cites this paper
• Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.

  2022cites this paper
• IRAK4 mediates colitis-induced tumorigenesis and IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer chemoresistance in colorectal cancer IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer IRAK4 mediates colitis-induced tumorigenes

  2022cites this paper
• Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer

  2022cites this paper
• Exploring NFκB pathway as a potent strategy to mitigate COVID-19 severe morbidity and mortality

  2022cites this paper
• Anticancer and Apoptotic Activity in Cervical Adenocarcinoma HeLa Using Crude Extract of Ganoderma applanatum

  2022cites this paper
• Computational Screening of the Natural Product Osthole and Its Derivates for Anti-Inflammatory Activity

  2022cites this paper
• Elderberries as a potential supplement to improve vascular function in a SARS-CoV-2 environment.

  2022cites this paper
• Transglutaminase-2 mediates acquisition of neratinib resistance in metastatic breast cancer

  2022cites this paper
• In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors

  2022cites this paper
• A computational approach to investigate constitutive activation of NF‐κB

  2022cites this paper
• On the Immunometabolic Role of NF-κB in Adipocytes

  2022cites this paper
• N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases

  2022cites this paper
• Cucurbitacin B Down-Regulates TNF Receptor 1 Expression and Inhibits the TNF-α-Dependent Nuclear Factor κB Signaling Pathway in Human Lung Adenocarcinoma A549 Cells

  2022cites this paper
• Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review

  2022cites this paper
• Dimers of isatin derived α-methylene-γ-butyrolactone as potent anti-cancer agents.

  2022cites this paper
• The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target

  2022cites this paper
• An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases

  2022cites this paper
• Skrining Inhibitor NF-κB Combretum indicum dengan Metode Docking

  2021cites this paper
• STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-κB signaling pathway

  2021cites this paper
• Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington’s Disease Models

  2021cites this paper
• NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors

  2021cites this paper
• Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action

  2021cites this paper
• Artemisia lactiflora Extracts Prevent Inflammatory Responses of Human Macrophages Stimulated with Charcoal Pyrolysis Smoke

  2021cites this paper
• Investigation of Leoligin Derivatives as NF-κΒ Inhibitory Agents

  2021cites this paper
• Dietary Isothiocyanates Inhibit Cancer Progression by Modulation of Epigenome.

  2021cites this paper
• Advances in Proteasome Enhancement by Small Molecules

  2021cites this paper
• Epididymal embryonic development harbors TLR4/NFKB signaling pathway as a morphogenetic player.

  2021cites this paper
• Insight Cross-talk between p53 and Toll-like Receptor

  2021cites this paper
• Potential health benefits of zinc supplementation for the management of COVID‐19 pandemic

  2021cites this paper
• NF-κB and Pancreatic Cancer; Chapter and Verse

  2021cites this paper
• Genetic variations and epigenetic modulations in CYP genes: Implications in NSAID-treatment of arthritis patients

  2021cites this paper
• COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway

  2021cites this paper
• SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection

  2021cites this paper
• The Role of Chronic Inflammation in the Development of Breast Cancer

  2021cites this paper
• NF-κB and Cancer Therapy Drugs

  2021cites this paper
• The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

  2021cites this paper
• Improving the Adjuvanticity of Small Molecule Immune Potentiators Using Covalently Linked NF-κB Modulators

  2021cites this paper
• Endotheliumprotectiv and antihypoxic properties of quercetin in elderly patients with metabolic syndrome

  2021cites this paper
• Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer.

  2021cites this paper
• In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response

  2021cites this paper
• Вивчення впливу дієтичної добавки Лізоферрин у жінок з метаболічним синдромом

  2021cites this paper
• Redox Role of ROS and Inflammation in Pulmonary Diseases.

  2021cites this paper